Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-02 @ 5:44 AM
Study NCT ID:
NCT05858567
Status:
UNKNOWN
Last Update Posted:
2023-05-15
First Post:
2023-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Total Neoadjuvant Therapy With Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Ultra Low Rectal Adenocarcinoma
Sponsor:
Sir Run Run Shaw Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-11
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-04
First Submit QC Date:
None
Study First Post Date:
2023-05-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-04
Last Update Post Date:
2023-05-15
Last Update Post Date Type:
ACTUAL